TuisAM6 • FRA
add
Amicus Therapeutics, Inc.
Vorige sluiting
€12,20
Dagwisseling
€12,20 - €12,20
Jaarwisseling
€4,80 - €12,40
Markkapitalisasie
4,51 mjd USD
Gemiddelde volume
77,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 185,21 m | 23,72% |
Bedryfskoste | 142,72 m | 20,03% |
Netto inkomste | 1,69 m | -88,53% |
Netto winsgrens | 0,91 | -90,76% |
Wins per aandeel | 0,10 | 11,11% |
EBITDA | 17,84 m | -0,94% |
Effektiewe belastingkoers | 46,23% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 293,54 m | 17,44% |
Totale bates | 949,87 m | 21,00% |
Totale aanspreeklikheid | 675,63 m | 14,32% |
Totale ekwiteit | 274,24 m | — |
Uitstaande aandele | 314,00 m | — |
Prys om te bespreek | 13,86 | — |
Opbrengs op bates | 4,38% | — |
Opbrengs op kapitaal | 5,74% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,69 m | -88,53% |
Kontant van bedrywe | 16,25 m | 515,04% |
Kontant van beleggings | -6,49 m | 68,15% |
Kontant van finansiering | 14,03 m | 1 178,85% |
Netto kontantverandering | 23,46 m | 216,69% |
Beskikbare kontantvloei | 18,09 m | 109,11% |
Meer oor
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Gestig
04 Feb. 2002
Webwerf
Werknemers
511
